ERK2 Mutations Affect Interactions, Localization, and Dimerization.

Area of Science:

• Molecular Biology
• Cell Signaling
• Cancer Genetics

Background:

• The common docking (CD) site of ERK2 (MAPK1) is crucial for interactions with activators, phosphatases, and substrates.
• The frequent cancer mutation E322K and the less common D321N affect the ERK2 CD site, suggesting altered kinase function.

Purpose of the Study:

• To investigate the functional properties of ERK2 E322K and D321N mutants.
• To understand how these mutations contribute to gain-of-function phenotypes observed in cancer.

Main Methods:

• Utilized Drosophila developmental assays to assess gain-of-function phenotypes.
• Analyzed protein-protein interactions, nuclear retention, dimerization, and crystal structure of ERK2 mutants.
• Employed sensitized melanoma and two-hybrid systems to evaluate mutant behavior.

Main Results:

• ERK2 E322K and D321N mutants exhibit gain-of-function phenotypes in Drosophila.
• Modest increases in nuclear retention for E322K were observed.
• Binding to some substrates was similar, but interactions with the F-site were reduced for E322K.
• ERK2 E322K showed reduced dimerization, though still present in EGF-treated cells.

Conclusions:

• Mutations in the ERK2 CD site, particularly E322K, lead to subtle functional alterations including changes in nuclear localization and dimerization.
• These distinct behavioral changes, despite similarities in substrate binding, likely contribute to the increased function of ERK2 E322K in certain cancers.